1. Home
  2. ACOG vs OMIC Comparison

ACOG vs OMIC Comparison

Compare ACOG & OMIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • OMIC
  • Stock Information
  • Founded
  • ACOG N/A
  • OMIC 2016
  • Country
  • ACOG Canada
  • OMIC United States
  • Employees
  • ACOG N/A
  • OMIC N/A
  • Industry
  • ACOG
  • OMIC Medical/Dental Instruments
  • Sector
  • ACOG
  • OMIC Health Care
  • Exchange
  • ACOG Nasdaq
  • OMIC Nasdaq
  • Market Cap
  • ACOG 32.4M
  • OMIC 34.9M
  • IPO Year
  • ACOG N/A
  • OMIC 2021
  • Fundamental
  • Price
  • ACOG N/A
  • OMIC $21.90
  • Analyst Decision
  • ACOG
  • OMIC Hold
  • Analyst Count
  • ACOG 0
  • OMIC 2
  • Target Price
  • ACOG N/A
  • OMIC $10.75
  • AVG Volume (30 Days)
  • ACOG N/A
  • OMIC 36.4K
  • Earning Date
  • ACOG N/A
  • OMIC 11-12-2024
  • Dividend Yield
  • ACOG N/A
  • OMIC N/A
  • EPS Growth
  • ACOG N/A
  • OMIC N/A
  • EPS
  • ACOG N/A
  • OMIC N/A
  • Revenue
  • ACOG N/A
  • OMIC $2,667,000.00
  • Revenue This Year
  • ACOG N/A
  • OMIC $10.41
  • Revenue Next Year
  • ACOG N/A
  • OMIC $222.15
  • P/E Ratio
  • ACOG N/A
  • OMIC N/A
  • Revenue Growth
  • ACOG N/A
  • OMIC 2.77
  • 52 Week Low
  • ACOG N/A
  • OMIC $5.34
  • 52 Week High
  • ACOG N/A
  • OMIC $23.41
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • OMIC 67.25
  • Support Level
  • ACOG N/A
  • OMIC $22.22
  • Resistance Level
  • ACOG N/A
  • OMIC $23.00
  • Average True Range (ATR)
  • ACOG 0.00
  • OMIC 1.06
  • MACD
  • ACOG 0.00
  • OMIC 0.33
  • Stochastic Oscillator
  • ACOG 0.00
  • OMIC 86.29

About OMIC Singular Genomics Systems Inc.

Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.

Share on Social Networks: